United States · FDA National Drug Code directory

ORSERDU

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
72187-0102_040abaf0-7a15-11f1-b55a-0800200c9a66
Product NDC
72187-0102
Form
TABLET, FILM COATED
Composition / generic term
Elacestrant
Labeler
Stemline Therapeutics, Inc.
Marketing category
NDA
Marketing start / end (source format)
20230127
Source listing expiry
20271231

Source-listed ingredients

  • ELACESTRANT — 345 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET, FILM COATED in 1 BOTTLE (72187-0102-3) · 72187-0102-3

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →